Deferoxamine for Iron Overload Before Allogeneic Stem Cell Transplantation

NCT00658411 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

5

Enrollment

OTHER

Sponsor class

Stopped Closed due to slow patient accrual

Conditions

Acute Myeloid Leukemia
Acute Lymphoblastic Leukemia
Myelodysplastic Syndrome

Interventions

DRUG: deferoxamine

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]